1.Hypoparathyroidism, sensorineural deafness, and renal dysgenesis syndrome with a GATA3 mutation.
Yong Suk SHIM ; Woohyeok CHOI ; Il Tae HWANG ; Seung YANG
Annals of Pediatric Endocrinology & Metabolism 2015;20(1):59-63
Hypoparathyroidism, sensorineural deafness, and renal dysgenesis syndrome is an autosomal dominant disease caused by mutations in the GATA3 gene on chromosome 10p15. We identified a patient diagnosed with hypoparathyroidism who also had a family history of hypoparathyroidism and sensorineural deafness, present in the father. The patient was subsequently diagnosed and found to be a heterozygote for an insertion mutation c.255_256ins4 (GTGC) in exon 2 of GATA3. His father was also confirmed to have the same mutation in GATA3.
Deafness*
;
Exons
;
Fathers
;
Hearing Loss, Sensorineural
;
Heterozygote
;
Humans
;
Hypoparathyroidism*
;
Mutagenesis, Insertional
2.Comparison of growth and pubertal progression in wild type female rats with different bedding types.
Byung Ho KANG ; Shin Hee KIM ; Kyung A JUNG ; So Youn KIM ; Sung Hoon CHUNG ; Young Shil PARK ; Kyung Lim YOON ; Kye Shik SHIM
Annals of Pediatric Endocrinology & Metabolism 2015;20(1):53-58
PURPOSE: Endocrine-disrupting chemicals interfere with the endocrine system and therefore affect growth and pubertal progression. The study aim was to compare the growth and pubertal progression in wild-type female rats with different bedding types. METHODS: Twenty 5-week-old female wild-type Sprague Dawley rats were randomly assigned to two groups with different bedding types: one group received wood shaving bedding, while a second group received corncob bedding. We determined crown-rump length and body weight as anthropometric measurements and assessed the serum growth hormone (GH) and estradiol levels. The gh1 mRNA expression levels were compared using quantitative real time transcription polymerase chain reaction. The estrous cycle was evaluated by vaginal smear. RESULTS: The anthropometric measurements were not significantly different between the two groups. The mean relative expression of the gh1 gene was lower in the corncob bedding group than that in the wood shaving group (P=0.768). Meanwhile serum GH and estradiol were increased in the wood shaving bedding group; however this difference was not statistically significant. The time to first estrus and the length of the estrous cycle were increased in the corncob bedding group; the proportion of normal estrous cycles was also decreased. These findings indicate irregularities in the estrous cycle. CONCLUSION: Endocrine-disrupting chemicals in corncob bedding might be associated with time to first estrus and length of the estrous cycle. Therefore, the type of bedding should be considered as a factor affecting pubertal progression in rodents.
Adolescent
;
Animals
;
Bedding and Linens
;
Body Weight
;
Crown-Rump Length
;
Endocrine Disruptors
;
Endocrine System
;
Estradiol
;
Estrous Cycle
;
Estrus
;
Female
;
Growth Hormone
;
Humans
;
Polymerase Chain Reaction
;
Puberty
;
Rats*
;
Rats, Sprague-Dawley
;
RNA, Messenger
;
Rodentia
;
Vaginal Smears
;
Wood
3.Relationship between serum 25-hydroxyvitamin D concentration and risks of metabolic syndrome in children and adolescents from Korean National Health and Nutrition Examination survey 2008-2010.
Dong Yup LEE ; Ah Reum KWON ; Jung Min AHN ; Ye Jin KIM ; Hyun Wook CHAE ; Duk Hee KIM ; Ho Seong KIM
Annals of Pediatric Endocrinology & Metabolism 2015;20(1):46-52
PURPOSE: Previous studies have revealed many inconsistent results regarding the relationship between vitamin D and metabolic syndrome. The purpose of our study was to investigate the association between serum 25-hydroxyvitamin D (25(OH)D) concentration and factors that characterize metabolic syndrome in Korean children and adolescents. METHODS: We analyzed data from 2,880 children and adolescents aged 10-18 years collected from the 2008-2010 Korean National Health and Nutrition Examination Survey. We investigated the data according to quartiles of 25(OH)D concentrations. RESULTS: Systolic blood pressure and diastolic blood pressure with adjustment for sex and age differed significantly between the serum 25(OH)D groups and exhibited negative trend as 25(OH)D concentrations increased. The number of subjects with metabolic syndrome was greater in the low 25(OH)D groups (I, II, and III quartile) than in the high 25(OH)D group (IV quartile) (P=0.029). BMI and waist circumference were lower in the high 25(OH)D group. Serum 25(OH)D concentration correlated negatively with homeostasis model assessment estimate of insulin resistance (rho=-0.073, P<0.001) and correlated positively with quantitative insulin sensitivity check index (rho=0.095, P<0.001). CONCLUSION: Low serum 25(OH)D level is associated with an increase of insulin resistance and metabolic syndrome in children and adolescents.
Adolescent*
;
Blood Pressure
;
Child*
;
Homeostasis
;
Humans
;
Insulin Resistance
;
Nutrition Surveys*
;
Obesity
;
Vitamin D
;
Waist Circumference
4.Birth seasonality in Korean Prader-Willi syndrome with chromosome 15 microdeletion.
Aram YANG ; Yeon Hee LEE ; Soon Young NAM ; Yu Ju JEONG ; Yechan KYUNG ; Rimm HUH ; Jieun LEE ; Younghee KWUN ; Sung Yoon CHO ; Dong Kyu JIN
Annals of Pediatric Endocrinology & Metabolism 2015;20(1):40-45
PURPOSE: Prader-Willi syndrome (PWS) is a well-known genetic disorder, and microdeletion on chromosome 15 is the most common causal mechanism. Several previous studies have suggested that various environmental factors might be related to the pathogenesis of microdeletion in PWS. In this study, we investigated birth seasonality in Korean PWS. METHODS: A total of 211 PWS patients born from 1980 to 2014 were diagnosed by methylation polymerase chain reaction at Samsung Medical Center. Of the 211 patients, 138 were born from 2000-2013. Among them, the 74 patients of a deletion group and the 22 patients of a maternal uniparental disomy (UPD) group were compared with general populations born from 2000 using the Walter and Elwood method and cosinor analysis. RESULTS: There was no statistical significance in seasonal variation in births of the total 211 patients with PWS (chi2=7.2522, P=0.2982). However, a significant difference was found in the monthly variation between PWS with the deletion group and the at-risk general population (P<0.05). In the cosinor model, the peak month of birth for PWS patients in the deletion group was January, while the nadir occurred in July, with statistical significance (amplitude=0.23, phase=1.2, low point=7.2). The UPD group showed the peak birth month in spring; however, this result was not statistically significant (chi2=3.39, P=0.1836). CONCLUSION: Correlation with birth seasonality was identified in a deletion group of Korean PWS patients. Further studies are required to identify the mechanism related to seasonal effects of environmental factors on microdeletion on chromosome 15.
Chromosomes, Human, Pair 15*
;
Humans
;
Methylation
;
Parturition*
;
Polymerase Chain Reaction
;
Prader-Willi Syndrome*
;
Seasons*
;
Uniparental Disomy
5.Etiologies and characteristics of children with chief complaint of short stature.
Kyung Chul SONG ; Song Lee JIN ; Ah Reum KWON ; Hyun Wook CHAE ; Jung Min AHN ; Duk Hee KIM ; Ho Seong KIM
Annals of Pediatric Endocrinology & Metabolism 2015;20(1):34-39
PURPOSE: Short stature is a very common reason for visits to pediatric endocrine clinics. It could be the first sign of an underlying disease. The purpose of this study is to investigate the etiologies and general characteristics of subjects who visited an outpatient clinic due to short stature. METHODS: We retrospectively reviewed the medical records of 3,371 patients who visited Severance Children's Hospital with the chief complaint of short stature from 2010 to 2012. Medical history, auxological data, and laboratory tests including bone age were collected and analyzed. Chromosome studies or combined pituitary function tests were performed if needed. RESULTS: Approximately 89.4% of the subjects with the chief complaint of short stature who visited the outpatient clinic were of normal height, and only 10.6% of subjects were identified as having short stature. Of the subject of short stature, 44.7% were classified as having normal variant short stature; that is, familial short stature (23.0%), constitutional delay in growth (17.7%), and mixed form (3.9%). Pathological short stature was found in 193 subjects (54.2%). Among pathological short stature, most common etiology was growth hormone deficiency (GHD) (38.9%). CONCLUSION: A majority of children had a normal height. Among children with short stature, pathological short stature and normal variants occupied a similar percentage. GHD was the most common cause of pathological short stature and found in about 20% of the children with short stature. In pathological short stature, the height, height velocity, and IGF-1 level were lower than in normal variants.
Ambulatory Care Facilities
;
Child*
;
Growth Hormone
;
Humans
;
Insulin-Like Growth Factor I
;
Medical Records
;
Pituitary Function Tests
;
Retrospective Studies
6.Clinical, endocrinological, and molecular characterization of Kallmann syndrome and normosmic idiopathic hypogonadotropic hypogonadism: a single center experience.
Sun Jeong SHIN ; Yeonah SUL ; Ja Hye KIM ; Ja Hyang CHO ; Gu Hwan KIM ; Jae Hyun KIM ; Jin Ho CHOI ; Han Wook YOO
Annals of Pediatric Endocrinology & Metabolism 2015;20(1):27-33
PURPOSE: Isolated gonadotropin-releasing hormone (GnRH) deficiency (IGD) is classified as Kallmann syndrome (KS) with anosmia and normosmic idiopathic hypogonadotropic hypogonadism (nIHH). This study was undertaken to investigate the clinical, endocrinological, and molecular characteristics in Korean patients with KS and nIHH. METHODS: Twenty-six patients from 25 unrelated families were included. Their clinical, endocrinological, and radiological findings were analyzed retrospectively. Mutation analysis of the GNRH1, GNRHR, KISS1, KISS1R, PROK2, PROKR2, TAC3, TACR3, FGF8, FGFR1, and KAL1 genes was performed in all patients. CHD7 and SOX10 were analyzed in patients with CHARGE (Coloboma, Heart defects, choanae Atresia, Growth retardation, Genitourinary abnormality, Ear abnormality) features or deafness. RESULTS: Of the 26 patients, 16 had KS and 10 had nIHH. At diagnosis, mean chronologic age was 18.1 years in males and 18.0 years in females; height SDS were -0.67+/-1.35 in males, -1.12+/-1.86 in females; testis volume was 2.0+/-1.3 mL; and Tanner stage was 1.5. There were associated anomalies in some of the KS patients: hearing loss (n=6) and congenital heart disease (n=4). Absence or hypoplasia of the olfactory bulb/sulci was found in 84.62% of patients with KS. Molecular defects in KAL1, SOX10, and CHD7 were identified in 5 patients from 4 families (16.0%, 4/25 pedigrees). After sex hormone replacement therapy, there were improvement in sexual characteristics and the sexual function. CONCLUSION: This study described the clinical, endocrinological, and molecular genetic features in IGD patients in Korea. Although the mutation screening was performed in 10 genes that cause IGD, molecular defects were identified in relatively small proportions of the cohort.
Cohort Studies
;
Deafness
;
Diagnosis
;
Ear
;
Female
;
Gonadotropin-Releasing Hormone
;
Hearing Loss
;
Heart
;
Heart Defects, Congenital
;
Hormone Replacement Therapy
;
Humans
;
Hypogonadism*
;
Immunoglobulin D
;
Kallmann Syndrome*
;
Korea
;
Male
;
Mass Screening
;
Molecular Biology
;
Nasopharynx
;
Olfaction Disorders
;
Retrospective Studies
;
Testis
;
Urogenital Abnormalities
7.Clinical usefulness of the measurement of serum fructosamine in childhood diabetes mellitus.
Dong Soo KANG ; Jiyun PARK ; Jae Kyung KIM ; Jeesuk YU
Annals of Pediatric Endocrinology & Metabolism 2015;20(1):21-26
PURPOSE: Glycosylated hemoglobin (HbA1c) is often used as an indicator of glucose control. It usually reflects the average glucose levels over two to three months, and is correlated with the development of long-term diabetic complications. However, it can vary in cases of hemoglobinopathy or an altered red blood cell lifespan. The serum fructosamine levels reflect the mean glucose levels over two to three weeks. This study was designed to determine the clinical usefulness of the combined measurement of serum fructosamine and HbA1c in the management of childhood diabetes mellitus and the correlation between them. METHODS: Clinical data on 74 Korean children and adolescents with diabetes mellitus who were under management at the Department of Pediatrics of Dankook University Hospital were evaluated. Their fructosamine and HbA1c levels were reviewed based on clinical information, and analyzed using IBM SPSS Statistics ver. 21. RESULTS: Their HbA1c levels showed a strong correlation with their fructosamine levels (r=0.868, P<0.001). The fructosamine level was useful for the prompt evaluation of the recent therapeutic efficacy after the change in therapeutic modality. It was also profitable in determining the initial therapeutics and for the estimation of the onset of the disease, such as fulminant diabetes. CONCLUSION: The measurement of both fructosamine and HbA1c was useful in managing childhood diabetes mellitus, especially when there was discrepancy between the clinical information and the HbA1c level.
Adolescent
;
Child
;
Diabetes Complications
;
Diabetes Mellitus*
;
Erythrocytes
;
Fructosamine*
;
Glucose
;
Hemoglobin A, Glycosylated
;
Hemoglobinopathies
;
Humans
;
Pediatrics
8.Regression and progression of microalbuminuria in adolescents with childhood onset diabetes mellitus.
Mi Kyung SON ; Ha Young YOO ; Byung Ok KWAK ; Hye Won PARK ; Kyo Sun KIM ; Sochung CHUNG ; Hyun Wook CHAE ; Ho Seong KIM ; Duk Hee KIM
Annals of Pediatric Endocrinology & Metabolism 2015;20(1):13-20
PURPOSE: Although microalbuminuria is considered as an early marker of nephropathy in diabetic adults, available information in diabetic adolescents is limited. The aim of this study was to investigate prevalence and frequency of regression of microalbuminuria in type 1 (T1DM) and type 2 diabetes mellitus (T2DM) patients with childhood onset. METHODS: One hundred and nine adolescents (median, 18.9 years; interquartile range (IQR), 16.5-21.0 years) with T1DM and 18 T2DM adolescents (median, 17.9 years; IQR, 16.8-18.4 years) with repeated measurements of microalbuminuria (first morning urine microalbumin/creatinine ratios) were included. The median duration of diabetes was 10.1 (7.8-14.0) years and 5.0 (3.5-5.6) years, respectively, and follow-up period ranged 0.5-7.0 years. Growth parameters, estimated glomerular filtration rate, glycosylated hemoglobin (HbA1c) and lipid profiles were obtained after reviewing medical record in each subject. RESULTS: The prevalence of microalbuminuria at baseline and evaluation were 21.1% and 17.4% in T1DM, and 44.4% and 38.9% in T2DM. Regression of microalbuminuria was observed in 13 T1DM patients (56.5%) and 3 T2DM patients (37.5%), and progression rate was 10.5% and 20% in T1DM and T2DM respectively. In regression T1DM group, HbA1c at baseline and follow-up was lower, and C-peptide at baseline was higher compared to persistent or progression groups. In T2DM, higher triglyceride was observed in persistent group. CONCLUSION: Considerable regression of microalbuminuria more than progression in diabetes adolescents indicates elevated urinary microalbumin excretion in a single test does not imply irreversible diabetic nephropathy. Careful monitoring and adequate intervention should be emphasized in adolescents with microalbuminuria to prevent rapid progression toward diabetic nephropathy.
Adolescent*
;
Adult
;
Albuminuria
;
C-Peptide
;
Child
;
Diabetes Mellitus*
;
Diabetes Mellitus, Type 1
;
Diabetes Mellitus, Type 2
;
Diabetic Nephropathies
;
Follow-Up Studies
;
Glomerular Filtration Rate
;
Hemoglobin A, Glycosylated
;
Humans
;
Medical Records
;
Prevalence
;
Triglycerides
9.Pubertal growth and epiphyseal fusion.
Annals of Pediatric Endocrinology & Metabolism 2015;20(1):8-12
The complex networks of nutritional, cellular, paracrine, and endocrine factors are closely related with pubertal growth and epiphyseal fusion. Important influencing factors include chondrocyte differentiation capacity, multiple molecular pathways active in the growth plate, and growth hormone-insulin-like growth factor-I axis activation and epiphyseal fusion through estrogen and its receptors. However, the exact mechanisms of these phenomena are still unclear. A better understanding of the detailed processes involved in the pubertal growth spurt and growth plate closure in longitudinal bone growth will help us develop methods to efficiently promote pubertal growth and delay epiphyseal fusion with fewer adverse effects.
Adolescent
;
Axis
;
Bone Development
;
Chondrocytes
;
Estrogens
;
Growth Plate
;
Humans
;
Puberty
10.Clinical and molecular review of atypical congenital adrenal hyperplasia.
Annals of Pediatric Endocrinology & Metabolism 2015;20(1):1-7
Congenital adrenal hyperplasia (CAH) is one of the most common inherited metabolic disorders. It comprises a group of autosomal recessive disorders caused by the mutations in the genes encoding for steroidogenic enzymes that involved cortisol synthesis. More than 90% of cases are caused by a defect in the enzyme 21-hydroxylase. Four other enzyme deficiencies (cholesterol side-chain cleavage, 17alpha-hydroxylase [P450c17], 11beta-hydroxylase [P450c11beta], 3beta-hydroxysteroid dehydrogenase) in the steroid biosynthesis pathway, along with one cholesterol transport protein defect (steroidogenic acute regulatory protein), and one electrontransfer protein (P450 oxidoreductase) account for the remaining cases. The clinical symptoms of the different forms of CAH result from the particular hormones that are deficient and those that are produced in excess. A characteristic feature of CAH is genital ambiguity or disordered sex development, and most variants are associated with glucocorticoid deficiency. However, in the rare forms of CAH other than 21-hydroxylase deficiency so-called "atypical CAH", the clinical and hormonal phenotypes can be more complicated, and are not well recognized. This review will focus on the atypical forms of CAH, including the genetic analyses, and phenotypic correlates.
Adrenal Hyperplasia, Congenital*
;
Cholesterol
;
Disorders of Sex Development
;
Genotype
;
Hydrocortisone
;
Phenotype
;
Rare Diseases
;
Sexual Development
;
Steroid 21-Hydroxylase